These results were recapitulated through silencing of SREBP2 using siRNA, which resulted in a decrease in cell viability, an increase in lipid ROS and lipid peroxidation in the MM cell lines [94]. The gene discussed is SREBF2; the disease is Miyoshi myopathy.